Page last updated: 2024-12-07

syringaresinol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Syringaresinol is a lignan, a type of natural compound found in plants. It exhibits various biological activities, including antioxidant, anti-inflammatory, and anticancer properties. Studies have shown its potential to inhibit the growth of certain cancer cells, including leukemia and breast cancer. It is also investigated for its ability to protect against neurodegenerative diseases. The synthesis of syringaresinol can be achieved through various methods, including enzymatic and chemical approaches. Due to its promising biological activities, syringaresinol is a subject of ongoing research to explore its therapeutic potential for various diseases.'

(+)-syringaresinol : The (7alpha,7'alpha,8alpha,8'alpha)-stereoisomer of syringaresinol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
Passerinagenus[no description available]ThymelaeaceaeA plant family of the order Myrtales, subclass Rosidae, class Magnoliopsida. They are mainly trees and shrubs. Many members contain mucilage and COUMARINS.[MeSH]
Passerinagenus[no description available]ThymelaeaceaeA plant family of the order Myrtales, subclass Rosidae, class Magnoliopsida. They are mainly trees and shrubs. Many members contain mucilage and COUMARINS.[MeSH]

Cross-References

ID SourceID
PubMed CID443023
CHEMBL ID361362
CHEBI ID47
SCHEMBL ID120484
MeSH IDM0124699
PubMed CID100067
CHEMBL ID4469429
CHEBI ID49211
SCHEMBL ID120485
MeSH IDM0124699

Synonyms (70)

Synonym
nsc-329246
(-) syringaresinol
4,4'-(1s,3ar,4s,6ar)-tetrahydro-1h,3h-furo[3,4-c]furan-1,4-diylbis(2,6-dimethoxyphenol)
(7alpha,7'alpha,8alpha,8'alpha)-3,3',5,5'-tetramethoxy-7,9':7',9-diepoxylignane-4,4'-diol
CHEBI:47 ,
(+)-syringaresinol
21453-69-0
4-[(3s,3ar,6s,6ar)-6-(4-hydroxy-3,5-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2,6-dimethoxyphenol
(+/-)-syringaresinol
CHEMBL361362
nsc 329246
unii-155k1084go
phenol, 4,4'-(tetrahydro-1h,3h-furo(3,4-c)furan-1,4-diyl)bis(2,6-dimethoxy-, (1s-(1alpha,3aalpha,4alpha,6aalpha))-
155k1084go ,
bdbm50349826
4-[(3s,3ar,6s,6ar)-6-(4-hydroxy-3,5-dimethoxy-phenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2,6-dimethoxy-phenol
SCHEMBL120484
syringaresinol, (+)-
(+)-lirioresinol b
phenol, 4,4'-((1s,3ar,4s,6ar)-tetrahydro-1h,3h-furo(3,4-c)furan-1,4-diyl)bis(2,6-dimethoxy-
KOWMJRJXZMEZLD-HCIHMXRSSA-N
AKOS030573572
Q7663351
phenol, 4,4'-(tetrahydro-1h,3h-furo(3,4-c)furan-1,4-diyl)bis(2,6-dimethoxy-, (1.alpha.,3a.alpha.,4.alpha.,6a.alpha.)-(+/-)-
syringaresinol, (+/-)-
6YWP8N8R9S ,
phenol, 4,4'-(tetrahydro-1h,3h-furo(3,4-c)furan-1,4-diyl)bis(2,6-dimethoxy-, (1r,3as,4r,6as)-rel-
phenol, 4,4'-(tetrahydro-1h,3h-furo(3,4-c)furan-1,4-diyl)bis(2,6-dimethoxy-, (1alpha,3aalpha,4alpha,6aalpha)-(+/-)-
unii-6ywp8n8r9s
rel-(1r,3as,4r,6as)-4,4'-(tetrahydro-1h,3h-furo(3,4-c)furan-1,4-diyl)bis(2,6-dimethoxyphenol)
MS-27315
F92974
CS-0090281
HY-126030
4,4'-(1s,3ar,4s,6ar)-tetrahydro-1h,3h-furo(3,4-c)furan-1,4-diylbis(2,6-dimethoxyphenol)
syringaresinol ,
4,4'-tetrahydro-1h,3h-furo[3,4-c]furan-1,4-diylbis(2,6-dimethoxyphenol)
3,3',5,5'-tetramethoxy-7,9':7',9-diepoxylignane-4,4'-diol
s(8-8)s
CHEBI:49211
4-[6-(4-hydroxy-3,5-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2,6-dimethoxyphenol
syringylresinol
3,3,5,5-tetramethoxy-7,9,7,9-diepoxylignan-4,4-diol
BMSE010057
4-[6-(4-hydroxy-3,5-dimethoxy-phenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2,6-dimethoxy-phenol
SCHEMBL120485
dl-syringaresinol
1177-14-6
phenol,4,4'-(tetrahydro-1h,3h-furo[3,4-c]furan-1,4-diyl)bis[2,6-dimethoxy-,(1r,3as,4r,6as)-rel-
21453-71-4
(+/-)-syringaresinol;
487-35-4
CHEMBL4469429
symplicosigenol
lirioresinol a
(+)-episyringaresinol
AKOS032948292
51152-20-6
4,4'-(tetrahydro-1h,3h-furo[3,4-c]furan-1,4-diyl)bis(2,6-dimethoxyphenol)
Q27121534
BCP19980
BCP19981
(-)-lirioresinol b;dl-syringaresinol
FT-0775764
A893311
BAA17714
phenol,4,4'-(tetrahydro-1h,3h-furo[3,4-c]furan-1,4-diyl)bis[2,6-dimethoxy-
CS-0142910
HY-N8307
FS-10194

Research Excerpts

Overview

Syringaresinol (SYR) is a natural abstract which possesses anti-inflammatory property. It could be found in various cereals and medicinal plants.

ExcerptReferenceRelevance
"Syringaresinol (SYR) is a natural abstract which possesses anti-inflammatory property."( Syringaresinol attenuates sepsis-induced cardiac dysfunction by inhibiting inflammation and pyroptosis in mice.
Cong, H; Li, D; Liu, J; Lu, Y; Tian, W; Wei, A; Yang, L; Zhuo, Y, 2021
)
2.79
"Syringaresinol (SYR) is a phenolic compound, which could be found in various cereals and medicinal plants. "( Syringaresinol Protects against Type 1 Diabetic Cardiomyopathy by Alleviating Inflammation Responses, Cardiac Fibrosis, and Oxidative Stress.
An, J; Feng, L; Gao, Y; Li, D; Li, G; Li, J; Li, Y; Liu, J; Qi, Z; Xu, Y; Yang, J; Yang, L, 2020
)
3.44

Effects

ExcerptReferenceRelevance
"Syringaresinol (SYR) has been reported to have anti-apoptotic and anti-inflammatory effects, but whether it could prevent pyroptosis to improve sepsis-induced ALI remains unclear."( Syringaresinol Resisted Sepsis-Induced Acute Lung Injury by Suppressing Pyroptosis Via the Oestrogen Receptor-β Signalling Pathway.
Cui, L; Hao, J; Li, C; Li, D; Li, J; Wang, X; Yang, L; Zhang, L; Zhang, Q; Zhang, S; Zhuo, Y, 2022
)
2.89
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (6)

ClassDescription
syringaresinolA lignan that is 7,9':7',9-diepoxylignane substituted by hydroxy groups at positions 4 and 4' and methoxy groups at positions 3, 3', 5 and 5' respectively.
lignanAny phenylpropanoid derived from phenylalanine via dimerization of substituted cinnamic alcohols, known as monolignols, to a dibenzylbutane skeleton. Note that while individual members of the class have names ending ...lignane, ...lignene, ...lignadiene, etc., the class names lignan, neolignan, etc., do not end with an "e".
polyphenolMembers of the class of phenols that contain 2 or more benzene rings each of which is substituted by at least one hydroxy group.
aromatic etherAny ether in which the oxygen is attached to at least one aryl substituent.
furofuranOrganic heterobicyclic compounds containing a two furan rings ortho-fused to each other.
polyetherAny ether that contains more than one ether linkage.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (5)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Polyphenol oxidase 2Agaricus bisporusIC50 (µMol)1,000.00000.03403.987110.0000AID610480
Arginase Leishmania amazonensisIC50 (µMol)13.70001.60002.28004.0000AID1066694
Tyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)IC50 (µMol)15.01000.00053.49849.7600AID1055972
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Peroxisome proliferator-activated receptor deltaHomo sapiens (human)EC50 (µMol)18.11000.00020.84609.1000AID1311999
Peroxisome proliferator-activated receptor deltaHomo sapiens (human)Kd27.62000.00040.62561.8000AID1312000
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (111)

Processvia Protein(s)Taxonomy
positive regulation of erythrocyte differentiationForkhead box protein O3Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIForkhead box protein O3Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIForkhead box protein O3Homo sapiens (human)
ovulation from ovarian follicleForkhead box protein O3Homo sapiens (human)
initiation of primordial ovarian follicle growthForkhead box protein O3Homo sapiens (human)
antral ovarian follicle growthForkhead box protein O3Homo sapiens (human)
oocyte maturationForkhead box protein O3Homo sapiens (human)
regulation of transcription by RNA polymerase IIForkhead box protein O3Homo sapiens (human)
mitochondrial transcriptionForkhead box protein O3Homo sapiens (human)
regulation of translationForkhead box protein O3Homo sapiens (human)
response to xenobiotic stimulusForkhead box protein O3Homo sapiens (human)
positive regulation of autophagyForkhead box protein O3Homo sapiens (human)
positive regulation of muscle atrophyForkhead box protein O3Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorForkhead box protein O3Homo sapiens (human)
negative regulation of cell migrationForkhead box protein O3Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayForkhead box protein O3Homo sapiens (human)
cellular response to oxidative stressForkhead box protein O3Homo sapiens (human)
cellular response to glucose starvationForkhead box protein O3Homo sapiens (human)
response to starvationForkhead box protein O3Homo sapiens (human)
positive regulation of apoptotic processForkhead box protein O3Homo sapiens (human)
positive regulation of neuron apoptotic processForkhead box protein O3Homo sapiens (human)
positive regulation of regulatory T cell differentiationForkhead box protein O3Homo sapiens (human)
negative regulation of neuron differentiationForkhead box protein O3Homo sapiens (human)
positive regulation of DNA-templated transcriptionForkhead box protein O3Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIForkhead box protein O3Homo sapiens (human)
brain morphogenesisForkhead box protein O3Homo sapiens (human)
canonical Wnt signaling pathwayForkhead box protein O3Homo sapiens (human)
response to fatty acidForkhead box protein O3Homo sapiens (human)
cellular response to glucose stimulusForkhead box protein O3Homo sapiens (human)
cellular response to corticosterone stimulusForkhead box protein O3Homo sapiens (human)
cellular response to hypoxiaForkhead box protein O3Homo sapiens (human)
response to dexamethasoneForkhead box protein O3Homo sapiens (human)
negative regulation of canonical Wnt signaling pathwayForkhead box protein O3Homo sapiens (human)
neuronal stem cell population maintenanceForkhead box protein O3Homo sapiens (human)
extrinsic apoptotic signaling pathway in absence of ligandForkhead box protein O3Homo sapiens (human)
positive regulation of hydrogen peroxide-mediated programmed cell deathForkhead box protein O3Homo sapiens (human)
positive regulation of miRNA transcriptionForkhead box protein O3Homo sapiens (human)
positive regulation of reactive oxygen species biosynthetic processForkhead box protein O3Homo sapiens (human)
cellular response to amyloid-betaForkhead box protein O3Homo sapiens (human)
cellular response to nerve growth factor stimulusForkhead box protein O3Homo sapiens (human)
response to water-immersion restraint stressForkhead box protein O3Homo sapiens (human)
regulation of neural precursor cell proliferationForkhead box protein O3Homo sapiens (human)
positive regulation of endothelial cell apoptotic processForkhead box protein O3Homo sapiens (human)
positive regulation of JUN kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein dephosphorylationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of signal transductionTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of signal transductionTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
actin cytoskeleton organizationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of endocytosisTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of vascular endothelial growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulum unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of intracellular protein transportTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cellular response to unfolded proteinTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
peptidyl-tyrosine dephosphorylationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
platelet-derived growth factor receptor-beta signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
IRE1-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor recyclingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of MAP kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of type I interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
growth hormone receptor signaling pathway via JAK-STATTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of protein tyrosine kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of ERK1 and ERK2 cascadeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of hepatocyte growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of IRE1-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of PERK-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of receptor catabolic processTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
glucose metabolic processPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
generation of precursor metabolites and energyPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
regulation of transcription by RNA polymerase IIPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
lipid metabolic processPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
fatty acid beta-oxidationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
apoptotic processPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
embryo implantationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
cholesterol metabolic processPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
cell population proliferationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
axon ensheathmentPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
fatty acid catabolic processPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
positive regulation of gene expressionPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
regulation of skeletal muscle satellite cell proliferationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
fatty acid transportPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
intracellular receptor signaling pathwayPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
cell-substrate adhesionPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
cellular response to nutrient levelsPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
wound healingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
steroid hormone mediated signaling pathwayPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
positive regulation of skeletal muscle tissue regenerationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
phosphatidylinositol 3-kinase/protein kinase B signal transductionPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
keratinocyte proliferationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
positive regulation of fat cell differentiationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
negative regulation of myoblast differentiationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
negative regulation of DNA-templated transcriptionPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
positive regulation of DNA-templated transcriptionPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
decidualizationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
negative regulation of epithelial cell proliferationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
keratinocyte migrationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
adipose tissue developmentPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
fat cell proliferationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
positive regulation of fat cell proliferationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
cellular response to hypoxiaPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
energy homeostasisPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
apoptotic signaling pathwayPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
negative regulation of miRNA transcriptionPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
glucose transmembrane transportPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
positive regulation of myoblast proliferationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
positive regulation of fatty acid metabolic processPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
fatty acid metabolic processPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
negative regulation of cholesterol storagePeroxisome proliferator-activated receptor deltaHomo sapiens (human)
cell differentiationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
negative regulation of inflammatory responsePeroxisome proliferator-activated receptor deltaHomo sapiens (human)
hormone-mediated signaling pathwayPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (31)

Processvia Protein(s)Taxonomy
transcription cis-regulatory region bindingForkhead box protein O3Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingForkhead box protein O3Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificForkhead box protein O3Homo sapiens (human)
transcription coregulator bindingForkhead box protein O3Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificForkhead box protein O3Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificForkhead box protein O3Homo sapiens (human)
DNA bindingForkhead box protein O3Homo sapiens (human)
DNA-binding transcription factor activityForkhead box protein O3Homo sapiens (human)
protein bindingForkhead box protein O3Homo sapiens (human)
beta-catenin bindingForkhead box protein O3Homo sapiens (human)
protein kinase bindingForkhead box protein O3Homo sapiens (human)
chromatin DNA bindingForkhead box protein O3Homo sapiens (human)
mitochondrial transcription factor activityForkhead box protein O3Homo sapiens (human)
sequence-specific DNA bindingForkhead box protein O3Homo sapiens (human)
sequence-specific double-stranded DNA bindingForkhead box protein O3Homo sapiens (human)
RNA bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
zinc ion bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
enzyme bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein kinase bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
receptor tyrosine kinase bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cadherin bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
ephrin receptor bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein phosphatase 2A bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
non-membrane spanning protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
transcription coactivator bindingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
DNA bindingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
DNA-binding transcription factor activityPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
nuclear steroid receptor activityPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
nuclear receptor activityPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
protein bindingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
zinc ion bindingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
lipid bindingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
linoleic acid bindingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
DNA-binding transcription factor bindingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
sequence-specific double-stranded DNA bindingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (17)

Processvia Protein(s)Taxonomy
mitochondrionForkhead box protein O3Homo sapiens (human)
mitochondrial matrixForkhead box protein O3Homo sapiens (human)
nucleusForkhead box protein O3Homo sapiens (human)
nucleoplasmForkhead box protein O3Homo sapiens (human)
cytoplasmForkhead box protein O3Homo sapiens (human)
mitochondrial outer membraneForkhead box protein O3Homo sapiens (human)
cytosolForkhead box protein O3Homo sapiens (human)
RNA polymerase II transcription repressor complexForkhead box protein O3Homo sapiens (human)
chromatinForkhead box protein O3Homo sapiens (human)
protein-containing complexForkhead box protein O3Homo sapiens (human)
nucleusForkhead box protein O3Homo sapiens (human)
plasma membraneTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
mitochondrial matrixTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
early endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulumTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytosolTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
mitochondrial cristaTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endosome lumenTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
sorting endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmic side of endoplasmic reticulum membraneTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein-containing complexTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulumTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
early endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
nucleusPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
nucleusPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
nucleoplasmPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
chromatinPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (89)

Assay IDTitleYearJournalArticle
AID332867Cytotoxicity against mouse P388 cells
AID744419Cytotoxicity against human MDA-MB-231 cells2013Bioorganic & medicinal chemistry letters, May-01, Volume: 23, Issue:9
Spirostanoids with 1,4-dien-3-one or 3β,7α-diol-5,6-ene moieties from Solanum violaceum.
AID1754175Antiinflammatory activity in mouse RAW264.7 assessed as inhibition of LPS-induced NO production preincubated for 30 mins followed by LPS stimulation measured after 24 hrs by Griess reagent based assay2021Journal of natural products, 05-28, Volume: 84, Issue:5
Tulipiferamide A, an Alkamide from
AID470168Antiestrogenic activity in human T47D cells assessed as drug level causing inhibition of 100 pM E2-enhanced cell proliferation to level equivalent to 1 pM E2 after 96 hrs by alamar blue assay2009Journal of natural products, Nov, Volume: 72, Issue:11
Antiestrogenic constituents of the Thai medicinal plants Capparis flavicans and Vitex glabrata.
AID1175634Binding affinity to His-tagged FOXO3a (unknown origin) by SPR analysis2015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
Enantioselective induction of SIRT1 gene by syringaresinol from Panax ginseng berry and Acanthopanax senticosus Harms stem.
AID1467123Cytotoxicity against human PANC1 cells after 72 hrs by WST8 assay2017Bioorganic & medicinal chemistry letters, 07-01, Volume: 27, Issue:13
Phytochemical and cytotoxic studies on the leaves of Calotropis gigantea.
AID404182Cytotoxicity against human A549 cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
Cytotoxic constituents from Brazilian red propolis and their structure-activity relationship.
AID1312030Activation of AMPK in mouse C2C12 myotubes assessed as increase in expression of phosphorylated AMPK at Thr-172 residue at 50 uM after 24 hrs by immunoblot method2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Syringaresinol induces mitochondrial biogenesis through activation of PPARβ pathway in skeletal muscle cells.
AID1055971Increase in 2-NBDG uptake in mouse 3T3L1 cells at 400 ug/ml after 30 mins by fluorescence spectrophotometry relative to DMSO-treated control2013Journal of natural products, Nov-22, Volume: 76, Issue:11
Protein tyrosine phosphatase 1B (PTP1B) inhibitors from Morinda citrifolia (Noni) and their insulin mimetic activity.
AID404184Cytotoxicity against human HT1080 cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
Cytotoxic constituents from Brazilian red propolis and their structure-activity relationship.
AID1312007Activation of PPARbeta in mouse C2C12 myotubes assessed as increase in PGC-1alpha mRNA level at 50 uM after 24 hrs by qRT-PCR method relative to control2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Syringaresinol induces mitochondrial biogenesis through activation of PPARβ pathway in skeletal muscle cells.
AID610480Inhibition of mushroom tyrosinase using L-DOPA after 10 mins by ELISA reader2011Journal of natural products, May-27, Volume: 74, Issue:5
Gusanlungionosides A-D, potential tyrosinase inhibitors from Arcangelisia gusanlung.
AID334387Cytotoxicity against human HT-29 cells after 7 days1992Journal of natural products, Mar, Volume: 55, Issue:3
Additional bioactive compounds and trilobacin, a novel highly cytotoxic acetogenin, from the bark of Asimina triloba.
AID1312013Activation of PPARbeta in mouse C2C12 myotubes assessed as induction of CPT1 protein expression at 50 uM after 24 hrs by immunoblot method relative to control2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Syringaresinol induces mitochondrial biogenesis through activation of PPARβ pathway in skeletal muscle cells.
AID404179Cytotoxicity against mouse colon 26-L5 cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
Cytotoxic constituents from Brazilian red propolis and their structure-activity relationship.
AID470161Stimulation of human MCF7 cell proliferation up to 100 uM after 96 hrs by alamar blue assay relative to estradiol2009Journal of natural products, Nov, Volume: 72, Issue:11
Antiestrogenic constituents of the Thai medicinal plants Capparis flavicans and Vitex glabrata.
AID1312010Activation of PPARbeta in mouse C2C12 myotubes assessed as increase in PGC-1alpha protein expression at 10 to 25 uM after 24 hrs by immunoblot method2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Syringaresinol induces mitochondrial biogenesis through activation of PPARβ pathway in skeletal muscle cells.
AID1312018Upregulation of PPARbeta protein expression in PPARbeta siRNA transfected mouse C2C12 myotubes at 50 uM after 24 hrs by immunoblot method2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Syringaresinol induces mitochondrial biogenesis through activation of PPARβ pathway in skeletal muscle cells.
AID470163Antiestrogenic activity in human MCF7 cells assessed as drug level causing inhibition of 100 pM E2-enhanced cell proliferation to level equivalent to 50 pM E2 after 96 hrs by alamar blue assay2009Journal of natural products, Nov, Volume: 72, Issue:11
Antiestrogenic constituents of the Thai medicinal plants Capparis flavicans and Vitex glabrata.
AID1312020Upregulation of PGC1-alpha protein expression in PPARbeta siRNA transfected mouse C2C12 myotubes at 50 uM after 24 hrs by immunoblot method relative to control2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Syringaresinol induces mitochondrial biogenesis through activation of PPARβ pathway in skeletal muscle cells.
AID334386Cytotoxicity against human MCF7 cells after 7 days1992Journal of natural products, Mar, Volume: 55, Issue:3
Additional bioactive compounds and trilobacin, a novel highly cytotoxic acetogenin, from the bark of Asimina triloba.
AID336586Cytotoxicity against human MCF7 cells after 7 days1992Journal of natural products, Oct, Volume: 55, Issue:10
Bioactive constituents from the twigs of Asimina parviflora.
AID1175628Induction of SIRT1 mRNA expression in HUVEC by quantitative RT-PCR analysis2015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
Enantioselective induction of SIRT1 gene by syringaresinol from Panax ginseng berry and Acanthopanax senticosus Harms stem.
AID1312002Induction of PPARbeta protein expression in mouse C2C12 myotubes at 50 uM after 24 hrs by immunoblot method2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Syringaresinol induces mitochondrial biogenesis through activation of PPARβ pathway in skeletal muscle cells.
AID1312000Binding affinity to recombinant PPARbeta-LBD (254 to 441 residues) (unknown origin) expressed in Escherichia coli Rosetta2 cells by isothermal titration calorimetry2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Syringaresinol induces mitochondrial biogenesis through activation of PPARβ pathway in skeletal muscle cells.
AID1625411Cytotoxicity against African green monkey Vero cells by sulforhodamine B assay2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Antimalarial Oxoprotoberberine Alkaloids from the Leaves of Miliusa cuneata.
AID1312026Induction of mitochondrial DNA content in PPARbeta siRNA transfected mouse C2C12 myotubes at 50 uM after 24 hrs by qRT-PCR method2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Syringaresinol induces mitochondrial biogenesis through activation of PPARβ pathway in skeletal muscle cells.
AID334384Cytotoxicity against human A549 cells after 7 days1992Journal of natural products, Mar, Volume: 55, Issue:3
Additional bioactive compounds and trilobacin, a novel highly cytotoxic acetogenin, from the bark of Asimina triloba.
AID744421Cytotoxicity against human HepG2 cells2013Bioorganic & medicinal chemistry letters, May-01, Volume: 23, Issue:9
Spirostanoids with 1,4-dien-3-one or 3β,7α-diol-5,6-ene moieties from Solanum violaceum.
AID1312001Induction of PPARbeta mRNA expression in mouse C2C12 myotubes at 50 uM after 24 hrs by qRT-PCR method relative to control2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Syringaresinol induces mitochondrial biogenesis through activation of PPARβ pathway in skeletal muscle cells.
AID243226Effect on stabilization of human topoisomerase I-DNA covalent complex at 100 uM2005Bioorganic & medicinal chemistry letters, Feb-01, Volume: 15, Issue:3
DNA topoisomerase I inhibitors from Rinorea anguifera.
AID1312008Activation of PPARbeta in mouse C2C12 myotubes assessed as induction of PGC-1alpha protein expression at 50 uM after 24 hrs by immunoblot method relative to control2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Syringaresinol induces mitochondrial biogenesis through activation of PPARβ pathway in skeletal muscle cells.
AID1312015Induction of mitochondrial biogenesis in mouse C2C12 myotubes assessed as increase in mitochondrial DNA content at 25 to 50 uM after 24 hrs by qRT-PCR method2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Syringaresinol induces mitochondrial biogenesis through activation of PPARβ pathway in skeletal muscle cells.
AID336585Cytotoxicity against human A549 cells after 7 days1992Journal of natural products, Oct, Volume: 55, Issue:10
Bioactive constituents from the twigs of Asimina parviflora.
AID404181Cytotoxicity against mouse LLC cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
Cytotoxic constituents from Brazilian red propolis and their structure-activity relationship.
AID1312033Induction of mitochondrial density in scramble siRNA transfected mouse C2C12 myotubes at 50 uM after 24 hrs by Mitotracker Green staining based fluorescence microscopic analysis2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Syringaresinol induces mitochondrial biogenesis through activation of PPARβ pathway in skeletal muscle cells.
AID1312014Activation of PPARbeta in mouse C2C12 myotubes assessed as induction of UCP2 protein expression at 50 uM after 24 hrs by immunoblot method relative to control2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Syringaresinol induces mitochondrial biogenesis through activation of PPARβ pathway in skeletal muscle cells.
AID334385Toxicity against brine shrimp larvae1992Journal of natural products, Mar, Volume: 55, Issue:3
Additional bioactive compounds and trilobacin, a novel highly cytotoxic acetogenin, from the bark of Asimina triloba.
AID1055972Inhibition of PTP1B (unknown origin) assessed as p-nitrophenol release from pNPP substrate after 30 mins by spectrophotometry2013Journal of natural products, Nov-22, Volume: 76, Issue:11
Protein tyrosine phosphatase 1B (PTP1B) inhibitors from Morinda citrifolia (Noni) and their insulin mimetic activity.
AID404180Cytotoxicity against mouse B16-BL6 cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
Cytotoxic constituents from Brazilian red propolis and their structure-activity relationship.
AID1175630Induction of SIRT1 mRNA expression in HUVEC after 24 hrs by luciferase reporter gene assay relative to untreated control2015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
Enantioselective induction of SIRT1 gene by syringaresinol from Panax ginseng berry and Acanthopanax senticosus Harms stem.
AID1312011Activation of PPARbeta in mouse C2C12 myotubes assessed as increase in CPT1 mRNA level at 50 uM after 24 hrs by qRT-PCR method relative to control2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Syringaresinol induces mitochondrial biogenesis through activation of PPARβ pathway in skeletal muscle cells.
AID1175632Cytotoxicity against HUVEC assessed as cell viability at 5 to 300 uM after 24 hrs by MTT assay2015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
Enantioselective induction of SIRT1 gene by syringaresinol from Panax ginseng berry and Acanthopanax senticosus Harms stem.
AID1312003Induction of PPARbeta mRNA expression in mouse C2C12 myotubes at <50 uM after 24 hrs by qRT-PCR method2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Syringaresinol induces mitochondrial biogenesis through activation of PPARβ pathway in skeletal muscle cells.
AID1434705Cytotoxicity against LPS-induced mouse N9 cells assessed as decrease in cell viability at 1 to 100 ug/ml after 24 hrs by MTT assay2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Natural potential neuroinflammatory inhibitors from Alhagi sparsifolia Shap.
AID1434704Antineuroinflammatory activity in mouse N9 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs by Griess assay2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Natural potential neuroinflammatory inhibitors from Alhagi sparsifolia Shap.
AID313354Cytotoxicity against human PANC1 cells in nutrient deprived medium after 24 hrs2008Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
Constituents of Brazilian red propolis and their preferential cytotoxic activity against human pancreatic PANC-1 cancer cell line in nutrient-deprived condition.
AID470167Antiestrogenic activity in human T47D cells assessed as drug level causing inhibition of 100 pM E2-enhanced cell proliferation to level equivalent to 10 pM E2 after 96 hrs by alamar blue assay2009Journal of natural products, Nov, Volume: 72, Issue:11
Antiestrogenic constituents of the Thai medicinal plants Capparis flavicans and Vitex glabrata.
AID470166Antiestrogenic activity in human T47D cells assessed as drug level causing inhibition of 100 pM E2-enhanced cell proliferation to level equivalent to 50 pM E2 after 96 hrs by alamar blue assay2009Journal of natural products, Nov, Volume: 72, Issue:11
Antiestrogenic constituents of the Thai medicinal plants Capparis flavicans and Vitex glabrata.
AID403754Antitubercular activity against Mycobacterium tuberculosis 90-2213872005Journal of natural products, Sep, Volume: 68, Issue:9
Antitubercular constituents from the stem wood of Cinnamomum kotoense.
AID610481Antimelanogenic activity in alpha-MSH-stimulated mouse B16F10 cells pretreated for 30 mins before alpha-MSH challenge measured after 48 hrs by ELISA reader2011Journal of natural products, May-27, Volume: 74, Issue:5
Gusanlungionosides A-D, potential tyrosinase inhibitors from Arcangelisia gusanlung.
AID744418Cytotoxicity against human A549 cells2013Bioorganic & medicinal chemistry letters, May-01, Volume: 23, Issue:9
Spirostanoids with 1,4-dien-3-one or 3β,7α-diol-5,6-ene moieties from Solanum violaceum.
AID1625412Antiplasmodial activity against chloroquine/antifolate-sensitive Plasmodium falciparum TM4 infected in human RBC incubated for 18 to 20 hrs by microdilution radioisotope method2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Antimalarial Oxoprotoberberine Alkaloids from the Leaves of Miliusa cuneata.
AID1066694Inhibition of Leishmania amazonensis recombinant arginase expressed in Escherichia coli Rosetta (DE3) pLysS using L-arginine as substrate incubated for 10 mins prior to substrate addition measured after 10 mins by colorimetry2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Isolation of arginase inhibitors from the bioactivity-guided fractionation of Byrsonima coccolobifolia leaves and stems.
AID336587Cytotoxicity against human HT-29 cells after 7 days1992Journal of natural products, Oct, Volume: 55, Issue:10
Bioactive constituents from the twigs of Asimina parviflora.
AID336584Toxicity in brine shrimp1992Journal of natural products, Oct, Volume: 55, Issue:10
Bioactive constituents from the twigs of Asimina parviflora.
AID1312017Induction of mitochondrial biogenesis in mouse C2C12 myotubes assessed as increase in mitochondrial density at 50 uM after 24 hrs by Mitotracker Green staining based fluorescence microscopic analysis relative to control2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Syringaresinol induces mitochondrial biogenesis through activation of PPARβ pathway in skeletal muscle cells.
AID243219Effect on DNA breakge as nicked FormII at 1 uM with topoisomerase I2005Bioorganic & medicinal chemistry letters, Feb-01, Volume: 15, Issue:3
DNA topoisomerase I inhibitors from Rinorea anguifera.
AID1312022Upregulation of CPT1 protein expression in PPARbeta siRNA transfected mouse C2C12 myotubes at 50 uM after 24 hrs by immunoblot method relative to control2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Syringaresinol induces mitochondrial biogenesis through activation of PPARβ pathway in skeletal muscle cells.
AID1256625Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production at 3 to 30 ug/ml after 24 hrs by Griess reaction2015Bioorganic & medicinal chemistry letters, Nov-15, Volume: 25, Issue:22
Inhibitory effects of compounds from Styrax obassia on NO production.
AID1055970Increase in 2-NBDG uptake in mouse 3T3L1 cells after 30 mins by fluorescence spectrophotometry2013Journal of natural products, Nov-22, Volume: 76, Issue:11
Protein tyrosine phosphatase 1B (PTP1B) inhibitors from Morinda citrifolia (Noni) and their insulin mimetic activity.
AID436320Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs2008Journal of natural products, Nov, Volume: 71, Issue:11
Phenylpropanoids from Daphne feddei and their inhibitory activities against NO production.
AID1175633Induction of FOXO3a binding to SIRT1 in HUVEC at 50 uM after 24 hrs by chromatin immunoprecipitation assay2015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
Enantioselective induction of SIRT1 gene by syringaresinol from Panax ginseng berry and Acanthopanax senticosus Harms stem.
AID610482Cytotoxicity against mouse B16F10 cells up to 200 ug/mL2011Journal of natural products, May-27, Volume: 74, Issue:5
Gusanlungionosides A-D, potential tyrosinase inhibitors from Arcangelisia gusanlung.
AID1312027Induction of mitochondrial density in PPARbeta siRNA transfected mouse C2C12 myotubes at 50 uM after 24 hrs by Mitotracker Green staining based fluorescence microscopic analysis2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Syringaresinol induces mitochondrial biogenesis through activation of PPARβ pathway in skeletal muscle cells.
AID1625413Antiplasmodial activity against multidrug-resistant Plasmodium falciparum K1 infected in human RBC incubated for 18 to 20 hrs by microdilution radioisotope method2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Antimalarial Oxoprotoberberine Alkaloids from the Leaves of Miliusa cuneata.
AID1312029Induction of SIRT1 protein expression in mouse C2C12 myotubes at 50 uM after 24 hrs by immunoblot method2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Syringaresinol induces mitochondrial biogenesis through activation of PPARβ pathway in skeletal muscle cells.
AID404183Cytotoxicity against human HeLa cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
Cytotoxic constituents from Brazilian red propolis and their structure-activity relationship.
AID1311999Activation of PPARbeta-LBD (unknown origin) assessed as fluorescein-labeled coactivator C33 recruitment by TR-FRET assay2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Syringaresinol induces mitochondrial biogenesis through activation of PPARβ pathway in skeletal muscle cells.
AID1190588Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production after 24 hrs by Griess assay2015Bioorganic & medicinal chemistry letters, Feb-15, Volume: 25, Issue:4
Inhibitory constituents of Sophora tonkinensis on nitric oxide production in RAW 264.7 macrophages.
AID1761969Analgesic activity against paclitaxel-induced cold allodynia in C57BL/6 mouse model at 10 mg/kg, po administered at day 14 and day 25 of post paclitaxel stimulation and measured after 1 hr2021Journal of natural products, 03-26, Volume: 84, Issue:3
Aromatic and Aliphatic Apiuronides from the Bark of
AID1312004Induction of PPARbeta protein expression in mouse C2C12 myotubes at <50 uM after 24 hrs by immunoblot method2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Syringaresinol induces mitochondrial biogenesis through activation of PPARβ pathway in skeletal muscle cells.
AID1192870Antiinflammatory activity in mouse RAW264.7 cells assessed as decrease in LPS-induced NO production after 24 hrs by Griess assay2015Bioorganic & medicinal chemistry letters, Mar-01, Volume: 25, Issue:5
Constituents of the stem barks of Ailanthus altissima and their potential to inhibit LPS-induced nitric oxide production.
AID470162Stimulation of human T47D cell proliferation up to 100 uM after 96 hrs by alamar blue assay relative to estradiol2009Journal of natural products, Nov, Volume: 72, Issue:11
Antiestrogenic constituents of the Thai medicinal plants Capparis flavicans and Vitex glabrata.
AID744422Cytotoxicity against human Hep3B cells2013Bioorganic & medicinal chemistry letters, May-01, Volume: 23, Issue:9
Spirostanoids with 1,4-dien-3-one or 3β,7α-diol-5,6-ene moieties from Solanum violaceum.
AID470165Antiestrogenic activity in human MCF7 cells assessed as drug level causing inhibition of 100 pM E2-enhanced cell proliferation to level equivalent to 1 pM E2 after 96 hrs by alamar blue assay2009Journal of natural products, Nov, Volume: 72, Issue:11
Antiestrogenic constituents of the Thai medicinal plants Capparis flavicans and Vitex glabrata.
AID1312012Activation of PPARbeta in mouse C2C12 myotubes assessed as increase in UCP2 mRNA level at 50 uM after 24 hrs by qRT-PCR method relative to control2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Syringaresinol induces mitochondrial biogenesis through activation of PPARβ pathway in skeletal muscle cells.
AID1312024Upregulation of UCP2 protein expression in PPARbeta siRNA transfected mouse C2C12 myotubes at 50 uM after 24 hrs by immunoblot method relative to control2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Syringaresinol induces mitochondrial biogenesis through activation of PPARβ pathway in skeletal muscle cells.
AID744420Cytotoxicity against human MCF7 cells2013Bioorganic & medicinal chemistry letters, May-01, Volume: 23, Issue:9
Spirostanoids with 1,4-dien-3-one or 3β,7α-diol-5,6-ene moieties from Solanum violaceum.
AID1190589Cytotoxicity against mouse RAW264.7 cells after 24 hrs by MTT assay2015Bioorganic & medicinal chemistry letters, Feb-15, Volume: 25, Issue:4
Inhibitory constituents of Sophora tonkinensis on nitric oxide production in RAW 264.7 macrophages.
AID470164Antiestrogenic activity in human MCF7 cells assessed as drug level causing inhibition of 100 pM E2-enhanced cell proliferation to level equivalent to 10 pM E2 after 96 hrs by alamar blue assay2009Journal of natural products, Nov, Volume: 72, Issue:11
Antiestrogenic constituents of the Thai medicinal plants Capparis flavicans and Vitex glabrata.
AID590972Inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells preincubated with compound for 1 hr before exposure to LPS measured after 24 hrs by Griess reaction method2011Bioorganic & medicinal chemistry letters, Apr-15, Volume: 21, Issue:8
Inhibition of nitric oxide production in lipopolysaccharide-stimulated RAW264.7 macrophage cells by lignans isolated from Euonymus alatus leaves and twigs.
AID1312032Induction of mitochondrial DNA content in scramble siRNA transfected mouse C2C12 myotubes at 50 uM after 24 hrs by qRT-PCR method2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Syringaresinol induces mitochondrial biogenesis through activation of PPARβ pathway in skeletal muscle cells.
AID1312009Activation of PPARbeta in mouse C2C12 myotubes assessed as increase in PGC-1alpha mRNA level at 10 to 25 uM after 24 hrs by qRT-PCR method2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Syringaresinol induces mitochondrial biogenesis through activation of PPARβ pathway in skeletal muscle cells.
AID1625410Cytotoxicity against human KB cells by sulforhodamine B assay2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Antimalarial Oxoprotoberberine Alkaloids from the Leaves of Miliusa cuneata.
AID1312016Induction of mitochondrial biogenesis in mouse C2C12 myotubes assessed as increase in mitochondrial density at 25 uM after 24 hrs by Mitotracker Green staining based fluorescence microscopic analysis relative to control2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Syringaresinol induces mitochondrial biogenesis through activation of PPARβ pathway in skeletal muscle cells.
AID243223Effect on DNA breakge as nicked FormII at 100 uM without topoisomerase I2005Bioorganic & medicinal chemistry letters, Feb-01, Volume: 15, Issue:3
DNA topoisomerase I inhibitors from Rinorea anguifera.
AID1659751Agonist activity at TRPA1 (unknown origin) at 1000 uM relative to AITC2020Bioorganic & medicinal chemistry letters, 06-01, Volume: 30, Issue:11
Identification of a new class of non-electrophilic TRPA1 agonists by a structure-based virtual screening approach.
AID1607902Inhibition of 5-lox (unknown origin) at 20 uM relative to control2019European journal of medicinal chemistry, Oct-01, Volume: 179Human disorders associated with inflammation and the evolving role of natural products to overcome.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (95)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (1.05)18.7374
1990's4 (4.21)18.2507
2000's22 (23.16)29.6817
2010's49 (51.58)24.3611
2020's19 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.33

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.33 (24.57)
Research Supply Index4.36 (2.92)
Research Growth Index5.64 (4.65)
Search Engine Demand Index42.09 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.33)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Reviews2 (2.60%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other24 (100.00%)84.16%
Other75 (97.40%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]